Globe Newswire
Expanded Portfolio Addresses Demand for Secure, High-Throughput Communications Across Swarm-Scale Unmanned Operations
Palo Alto, California, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Mobilicom Limited (Nasdaq: MOB) (“Mobilicom” or the “Company”), a provider of cybersecure solutions for drones and robotics today announced its participation in the Association of the United States Army’s (AUSA) 2026 Annual Meeting & Exposition, October 12–14 in Washington, D.C., and the... (continue reading...)
Deployment on Google Cloud Platform is designed to enhance computational capacity, data governance and operational flexibility as MitoCareX advances its drug discovery programs
Ness Ziona, Israel, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Nexentis Technologies Inc. (“Nexentis”), (NASDAQ: NXTS) (“Nexentis” or the “Company”), today announced that MitoCareX Bio Ltd. (“MitoCareX”), its wholly owned subsidiary, now deploys its Computational Drug Discovery Infrastructure on Google... (continue reading...)
TORONTO, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Are Canadians the cautious investors that the stereotype would have us believe? Or are they ready to go beyond the default options and play a more active role in creating their own wealth? According to data in the inaugural Canadian Momentum Project (CMP), released today by Purpose Unlimited (Purpose), it’s the latter: Canadians are eager to seize new opportunities. It’s the default system for growing wealth that holds them... (continue reading...)
MIRABEL, Québec, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Volatus Aerospace Inc. (TSX: FLT) (OTCQX: TAKOF) (Frankfurt: ABB.F) (“Volatus” or the “Company”), a Canadian-headquartered global aerospace and defence company, today announced that it has completed delivery of the uncrewed aircraft fleet under the initial approximately C$4.5 million tranche of its previously announced ISR training system contract with a NATO partner.
The contract, announced on December 15, 2025, has... (continue reading...)
CINCINNATI, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Hillman Solutions Corp. (Nasdaq: HLMN) (“Hillman”), a leading provider of hardware and related products, plans to host a conference call to discuss its results for the thirteen and thirty-nine weeks ended September 26, 2026 on Tuesday, November 3, 2026 at 8:30 a.m. Eastern Time. Hillman plans to issue its earnings release after market close on Monday, November 2, 2026.
President and Chief Executive Officer Jon Michael... (continue reading...)
More Globe Newswire
View Older Stories-
Crane NXT Appoints Jeong H. Kim to Board of Directors
-
Beam Global Signs Definitive Agreement to Acquire Drone Technology Company ScoutDI, Creating a Vertically Integrated U.S. Drone Platform for Industrial and Defense Markets
-
Atlantic HPC Group Inc Appoints Leo Lin as Chief Executive Officer
-
Sportradar Announces Agreement for the Divestiture of Coaching and Scouting Business of Synergy Sports to Teamworks Innovations
-
BrewDog Rallies Beer Lovers Across the UK to Choose Craft
-
Caspian Therapeutics and Kura Oncology to Host Investor Webcast Highlighting Caspian’s Launch and KO-7246 Preclinical Data in Diabetes
-
ProVen Growth and Income VCT plc: Issue of Equity and Closure of Offer for Subscription
-
Form 8.3 - Ramsdens Holdings Plc
-
ProVen VCT plc: Issue of Equity and Closure of Offer for Subscription
-
CHARM Therapeutics announces first patient dosed and first cohort fully enrolled in its Phase I/II clinical trial of CHM-029 for Acute Myeloid Leukemia
-
Gilat Secures Over $10 Million in Additional SkyEdge IV Orders from a Leading Satellite Operator
-
Kane Biotech to Present Clinical Data and Showcase revyve® Product Line at SAWC Fall 2026
-
OrthoPediatrics Expands Its Lower Extremity Bracing Portfolio with the Launch of OPSB® Knee 'TractorFIX
-
Lantronix CEO to Meet with Investors and Defense Customers at AUSA 2026
-
Zenas BioPharma Announces Upcoming Presentations of Orelabrutinib Data in Relapsing Remitting Multiple Sclerosis, Clinical Trial Designs in Progressive Multiple Sclerosis and Other Multiple Sclerosis
-
OrthoPediatrics Expands Its Lower Extremity Bracing Portfolio with the Launch of OPSB® Knee 'TractorFIX
-
Form 8.3 - Brave Bison Group Plc
-
Albion Crown VCT PLC: Annual Financial Report
-
Premier American Uranium Reports 10 ft of 0.064% eU₃O₈ in Ongoing Drilling at Kaycee, Wyoming
-
VERAXA Biotech Provides Overview on Implementation of FDA-Aligned Human-Relevant Models into R&D Strategy
-
Atavistik Bio to Present at the Cure HHT 16th International Scientific Conference
-
Cadrenal Therapeutics Retains Tungsten Advisors to Lead Formal Strategic Process to Maximize Value of its Orphan Thrombo-Inflammatory Therapeutics
-
NexLiving Communities to Present at the Cantech Investment Conference in Toronto
-
Q2 Metals Extends Near Surface Mineralization 100 Metres North at the Cisco Lithium Project, Intercepting 134.5 Metres at 1.20% Li₂O and 101.6 Metres at 1.02% Li₂O
-
Sono-Tek Announces Fiscal Second Quarter and First Half 2027 Earnings Conference Call
-
Capital City Bank Group, Inc. to Announce Quarterly Earnings Results on Tuesday, October 20, 2026
-
Omni Bridgeway Closes US$1 Billion Legal Finance Fundraise
-
OR Royalties Announces Preliminary Q3 2026 GEO Deliveries
-
Axsome Therapeutics to Report Third Quarter 2026 Financial Results on November 2
-
BillionToOne’s Tissue-Free Northstar Response® Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds
-
Amplify ETFs Launches Top 10™ Semiconductors ETF (CPU), Expanding Top 10™ Suite
-
Badass Capital Fund I Reports 39.92% Net Return In Q3 2026
-
Arvinas Shares Novel Oculomotor and Biomarker Data from Phase 1 Clinical Trial of ARV-102 in Patients with Parkinson’s Disease
-
Matchpoint Therapeutics Announces $150 Million Series B Financing to Advance Pipeline of First-In-Class Oral Small Molecules for Autoimmune and Inflammatory Diseases
-
Freight Right Launches MCP, Bringing Freight Quoting, Tracking and Booking Into AI Assistants
-
Noah Closes $38m Seed Funding Round as Major Enterprises Move Cross-Border Payments onto Stablecoin
-
Marex announces changes to Group Board
-
VERAXA Biotech Provides Overview on Implementation of FDA-Aligned Human-Relevant Models into R&D Strategy
-
Novartis advances multiple sclerosis innovation with late-breaking remibrutinib and broad portfolio data at MSToronto2026
-
YieldMax® ETFs Announces Weekly Distributions for Group 2 ETFs
-
Reliance, Inc. to Announce Third Quarter 2026 Results on Wednesday, October 21st
-
Form 8.5 (EPT/RI)-Pollen Street Group Limited
-
Orvessa Hayes LLC Expands Cross-Border Investment and Business Network Across Asia
-
NorthWest Intersects 41.7 Metres of 0.40% Copper and 0.67 g/t Gold (1.13% CuEq) at Kwanika North Pit Extension from 72.6 Metres
-
Notification under Chapter 9, Section 10 of the Securities Market Act: Holdings of Liedon Säästöpankkisäätiö in Oma Savings Bank Plc decreased below 10 percent
-
Form 8.5 (EPT/RI)- Gamma Communications Plc
-
Form 8.5 (EPT/RI)-Gooch & Housego plc
-
Perspective Therapeutics Announces Acceptance of [212Pb]VMT-α-NET Data for Presentation at the NANETS 2026 Multidisciplinary NET Medical Symposium
-
Major Shareholder Announcement
-
Alpha Compute’s GAMEE Reports Q3 Record 94% YoY Growth, Reaches Monthly Profitability with over 118 million game-plays, Expands Into AI-Powered Consumer Applications
